Warren Buffett fit · Grandes empresas a precio justo
Is Gyre Therapeutics, Inc. Common Stock (GYRE) a Warren Buffett Stock?
Low Buffett fit — meets only 3/9 criteria; valuation, moat, or financial health flags risk.
20/100
FNo encaja
3/9 criterios cumplidos
Los criterios de Warren Buffett, aplicados a GYRE
ROIC ≥ 15%
clave11.7%
Gross margin ≥ 40%
clave95.5%
Owner earnings yield ≥ 5%
clave1.2%
5y profitable
clave
Cómo se valora GYRE en otras estrategias
Datos financieros en vivo
Cap. mercado
$731.67M
PER (TTM)
55.7x
ROIC (TTM)
11.69%
Margen bruto
95.48%
Preguntas frecuentes
What is GYRE's Warren Buffett fit score?
GYRE scores 20/100 on our Warren Buffett fit engine — grade F. Low Buffett fit — meets only 3/9 criteria; valuation, moat, or financial health flags risk.
Does Warren Buffett actually own GYRE?
Our score is computed from financial fundamentals against Warren Buffett's published criteria. We don't claim that Warren Buffett personally owns or recommends GYRE.
How often is this score updated?
GYRE's Warren Buffett fit score is recomputed daily from the latest TTM financials.
Herramienta educativa, no es asesoramiento financiero. Las puntuaciones se calculan a partir de datos financieros públicos contra los criterios publicados de cada estrategia de inversión. No afirmamos que Warren Buffett posea o recomiende GYRE personalmente.